David Aron, MD

home / authors / david-aron-md

Articles

Site Logo
August 1st 2007

Who Should Receive Optimal Diabetes Care?

Gail M. Amundson, MD George J. Isham, MD Reply by Leonard M. Pogach, MD, MBA David Aron, MD Donald R. Miller, ScD

Site Logo
March 1st 2007

Should Mitigating Comorbidities Be Considered in Assessing Healthcare Plan Performance in Achieving Optimal Glycemic Control?

Leonard M. Pogach, MD, MBA Anjali Tiwari, MS Miriam Maney, MS Mangala Rajan, MBA Donald R. Miller, ScD David Aron, MD

Site Logo
November 1st 2005

Continuity of Care and Cardiovascular Risk Factor Management: Does Care by a Single Clinician Add to Informational Continuity Provided by Electronic Medical Records?

David Litaker, MD, PhD Cory Ritter, MD Scott Ober, MD, MBA David Aron, MD

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Hurricane | Image credit: Satoshi Kina - stock.adobe.com
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Opdivo packaging | Image credit: Bristol Myers Squibb
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Acute myeloid leukemia | Image: St Jude Children's Research Center
Published: September 19th 2024 | Updated: November 21st 2024
Institute for Value-Based Medicine®: Speakers Use AML Studies to Illustrate Effects of Disparities, Neighborhood Stress on Outcomes

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo